| abstract |
The present invention relates to a pharmaceutical composition comprising 17.alpha.-acetoxy-11.beta.-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione (CDB-2914) for use in treating endometriosis or pain associated therewith, or uterine fibroids, by daily administration of 5 mg to 20 mg thereof to the vaginal mucosa of a female patient in need thereof for a period of at least 4 months.n nCDB-2914 |